ArticleACS nano2025
Single-MicroRNA Detection on High-Selectivity Metasurface Fluorescence Biosensors.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Nanoparticle Detection Using Quasi-Bound States in the Continuum Supported by Silicon Metasurfaces.Small methods · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Next-generation diagnostics is expected to use the abundant data on living bodies and provide sufficiently useful healthcare information. A significant portion of the data are considered to be collected from microRNAs (miRNAs), which play crucial roles in various activities inside the body. Here, we demonstrate single-miRNA detection using metasurface fluorescence (FL) biosensors, which are optimized all-dielectric nanostructured surfaces featuring excellent FL detection capability. Ultimate high-sensitivity discrimination of one miRNA from zero miRNA is achieved at the subattomolar level by employing optimized reverse transcription (RT) of miRNAs, polymerase chain reaction (PCR) suppressing false reactions, and highly efficient and target-selective FL detection of the miRNA amplicons on the metasurface biosensors using appropriately designed oligo DNA probes. This degree of precision has never been obtained using any other technique, such as digital PCR, which is currently one of the most efficient techniques. Furthermore, we demonstrate the specific detection of a cancer-correlated miRNA that is deeply mixed with another miRNA. We also examine and discuss other methods that possibly work for miRNA detection at femtomolar or lower concentrations, such as chromatography and different amplification methods, including handy one-step RT-PCR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.